RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
RSV vaccine study tests multidose vial safety in women
⭐️ VACCINE ⭐️ CompletedThis study tested an RSV vaccine in 453 healthy women aged 18-49. It compared a single-dose vial to a multidose vial that includes a preservative to prevent germ growth. The goal was to see if both versions are safe and produce a similar immune response. Participants received one…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 08:15 UTC
-
RSV vaccine study: do nursing home residents get same protection?
⭐️ VACCINE ⭐️ CompletedThis study looked at how well new RSV vaccines work in adults over 60 living in long-term care facilities compared to those living at home. Researchers measured antibody levels before and after vaccination in 152 participants. The goal was to see if the immune response is similar…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC
-
One visit, two vaccines: study tests combining RSV and shingles shots
⭐️ VACCINE ⭐️ CompletedThis study looked at whether giving the RSV vaccine and the shingles vaccine at the same time is safe and works well in adults aged 50 and older. About 526 healthy or stable participants received either both vaccines together or one alone. Researchers measured immune responses an…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:51 UTC